Ex parte BRANDAZZA et al. - Page 2




                 Appeal No. 94-1484                                                                                                                     
                 Application 07/536,556                                                                                                                 



                 Accordingly, claims 2, 4, 5, and 7 through 9 are presented for consideration in this                                                   
                 appeal.                                                                                                                                
                          Claim 9 is illustrative of the subject matter on appeal and reads as follows:                                                 
                          9.  A method for the preparation of non-glycosylated pro-UK, characterized in                                                 
                 that non-glycosylated human pro-UK is expressed under the control of the E. coli                                                       
                 promoter Ptrp and the Shine-Dalgarno sequence MS-2 by E. coli B wherein the                                                            
                 sequence comprising the Shine-Dalgarno sequence MS-2, the ATG start codon and the                                                      
                 beginning of the pro-UK gene, flanked upstream by a HindIII site and downstream by a                                                   
                 TaqI site is as follows:                                                                                                               
                          HindIII                                                                                                                       
                          5N -AGCTTTAATAGACGCCGGCCATTCAAACATGAGGATTACCCATGAGC                                                                           
                          3N -AATTATCTGCGGCCGGTAAGTTTGTACTCCTAATGGGTACTCG                                                                               
                                            TaqI                                                                                                        
                          AATGAACTTCATCAAGTTCCAT-3N                                                                                                     
                          TTACTTGAAGTAGTTCAAGGTAGC-5N                                                                                                   
                          and said HindIII site is downstream of the promoter Ptrp.                                                                     

                                                                                          2                                                             
                          The references relied upon by the examiner are :                                                                              

                          2In addition, the examiner cites a reference to Kane (Kane et al., “Formation of                                              
                 Recombinant Protein Inclusion Bodies in Escherichia coli, TIBTECH, vol. 6, pp. 95-101                                                  
                 (1988)) at page 2 of the Examiner’s Answer.  However, the examiner does not rely                                                       
                 upon Kane in the statement of the rejection.  Rather, the examiner cites Kane at page 9                                                
                 of the Examiner’s Answer “for evidentiary purposes only.”  As pointed out by the court                                                 
                 in In re Hoch, 428 F.2d 1341, 1342 n.3, 166 USPQ 406, 407 n.3 (CCPA 1970), “[w]here                                                    
                                                                                                                    (continued...)                      
                                                                           2                                                                            





Page:  Previous  1  2  3  4  5  6  7  Next 

Last modified: November 3, 2007